BrightPath Bio and Cellistic Announces Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT cell December 14, 2024
RayStation in clinical use for proton arc therapy at the Trento Proton Therapy Center December 6, 2024
ExpreS2ion announces approval to initiate a Phase I clinical trial of ES2B-C001, its novel therapeutic vaccine, being developed for HER2-expressing breast cancer December 2, 2024
Novotech Publishes Comprehensive Report on the Global Vaccine Clinical Trials Landscape November 23, 2024
Novotech Releases Report on Global Bladder Cancer Clinical Trials, Offering Insights for Oncology Advancement November 21, 2024
Lytix Biopharma Q3 2024: Positive clinical results and strategic advancements strengthen path to commercialization November 19, 2024
Novotech Releases Comprehensive Report on the Global Clinical Trial Landscape for Small Cell Lung Cancer (SCLC) November 19, 2024
Medidata Secures Highest Leadership Position in Everest Group’s First Life Sciences Clinical Trial Management System Products PEAK Matrix® Assessment November 14, 2024
